Perianal Sclerotherapy
Not Applicable
Recruiting
- Conditions
- Rectal Prolapse.Rectal prolapseK62.3
- Registration Number
- IRCT20150114020663N6
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with recurrent rectal prolapse after maintenance treatment for three to six months
Exclusion Criteria
Patients with idiopathic prolapse with a history of less than six months
Patients with iatrogenic prolapse after pull-through surgery
Patients with rectal prolapse due to psychological issues
Patients with long intussusception removed from the rectum
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of rectal prolapse. Rectal bleeding. Timepoint: 6 month. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method Anal stenosis. Timepoint: Every three months. Method of measurement: Physical examination.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying rectal prolapse in pediatric patients treated with transanal sclerotherapy in IRCT20150114020663N6?
How does transanal sclerotherapy compare to surgical interventions for rectal prolapse in children in terms of efficacy and recurrence rates?
Are there specific biomarkers that can identify pediatric rectal prolapse patients likely to respond to sclerotherapy in Tabriz hospital studies?
What are the long-term adverse events associated with transanal sclerotherapy for rectal prolapse in children as reported in IRCT20150114020663N6?
What combination therapies or alternative approaches have been explored alongside sclerotherapy for pediatric rectal prolapse in Iranian clinical research?